In Reply: SARS-CoV-2 Vaccination Related, Pediatric Guillain-Barre Syndrome Requires the Same Management As in Adults
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Shahrizaila N, Lehmann H, Kuwabara S
. Guillain-Barré syndrome. Lancet. 2021; 397(10280):1214-1228.
DOI: 10.1016/S0140-6736(21)00517-1.
View
2.
Leonhard S, Mandarakas M, Gondim F, Bateman K, Ferreira M, Cornblath D
. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019; 15(11):671-683.
PMC: 6821638.
DOI: 10.1038/s41582-019-0250-9.
View
3.
Yi Wong A, Umapathi T, Nishimoto Y, Wang Y, Chan Y, Yuki N
. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes. J Peripher Nerv Syst. 2015; 20(1):47-51.
DOI: 10.1111/jns.12104.
View
4.
Meulstee J, van der Meche F
. Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. J Neurol Neurosurg Psychiatry. 1995; 59(5):482-6.
PMC: 1073708.
DOI: 10.1136/jnnp.59.5.482.
View
5.
Hadden R, Cornblath D, Hughes R, Zielasek J, Hartung H, Toyka K
. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 1998; 44(5):780-8.
DOI: 10.1002/ana.410440512.
View